Stent Grafts Market in China 2014-2018
- ID: 2686197
- October 2013
- Region: China
- 52 Pages
The analysts forecast the Stent Grafts market in China to grow at a CAGR of 18.09 percent over the period 2014-2018. One of the key factors contributing to this market growth is the increase in the aging population. The Stent Grafts market in China has also been witnessing an increasing demand for minimally invasive surgeries. However, the complications in patients' health post-surgery could pose a challenge to the growth of this market.
The report, the Stent Grafts Market in China 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report focuses on China; it also covers the Stent Grafts market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this market space are Medtronic Inc., Cook Medical Inc., Lifetech Scientific (Shenzhen) Co. Ltd., and Shanghai MicroPort Medical (Group) Co. Ltd.
The other vendors mentioned in the report are Terumo Cardiovascular Systems Corp., and W. L. Gore & Associates Inc.
Key questions answered in this report:
- What will the market size be in 2018 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Category
07.1 Stent Grafts Market in China by Category
07.1.1 AAA Stent Grafts
07.1.2 TAA Stent Grafts
08. Buying Criteria
09. Market Growth Drivers
10. Drivers and their Impact
11. Market Challenges
12. Impact of Drivers and Challenges
13. Market Trends
14. Trends and their Impact
15. Vendor Landscape
15.1 Competitive Scenario
15.1.1 Key News
15.1.2 Mergers and Acquisitions
15.2 Market Share Analysis 2012
15.3 Other Prominent Vendors
16. Key Vendor Analysis
16.1 Medtronic Inc.
16.1.1 Business Overview
16.1.2 Business Segmentation
16.1.3 Key Information
16.1.4 SWOT Analysis
16.2 Cook Medical Inc.
16.2.1 Business Overview
16.2.2 Business Segmentation
16.2.3 Key Information
16.2.4 SWOT Analysis
16.3 Lifetech Scientific (Shenzhen) Co. Ltd.
16.3.1 Business Overview
16.3.2 Key Information
16.3.3 SWOT Analysis
16.4 Shanghai MicroPort Medical (Group) Co. Ltd.
16.4.1 Business Overview
16.4.2 Business Segmentation
16.4.3 Key Information
16.5.1 SWOT Analysis
17. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Stent Grafts market in China Segmentation
Exhibit 3: Stent Grafts Market in China 2013-2018 (US$ million)
Exhibit 4: Stent Grafts market in China by Category Segmentation 2013
Exhibit 5: Business Segmentation of Medtronic Inc.
Exhibit 6: Business Segmentation of Cook Medical Inc.
Exhibit 7: Business Segmentation of Shanghai MicroPort Medical (Group) Co. Ltd.
Commenting on the report, an analyst from the team said: “There is an increasing demand for minimally invasive surgery among the rapidly increasing aging population across the world, and this is expected to propel the growth of the Stent Grafts market in China. Minimally invasive endovascular procedures are performed through minute incisions in the body. Such procedures can be used to treat plaque blockages in the arteries of the heart and other vessel walls of peripheral organs such as kidneys and brain. The principal advantage of these procedures over conventional surgical methods is the short recovery time, short length of the scars resulting in less physical trauma, low risk of infection, minimized bleeding, low cost, and shorter hospital stays.”
According to the report,one of the key drivers in this market is the increase in the number of aged population in this region. Due to this rapid growth rate of the aged population in China, the country is experiencing a simultaneous increase in the number of cardiovascular and peripheral diseased patients.
Further, the report states that one of the major challenges in the market is the risk related to patients' health post implants of stent grafts. Patients may suffer from blood leakages, a blockage of the flow of blood through the stent graft, misplacement of the stent graft, and infections.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.